5-Bromo-1-fluoro-2-(methoxymethoxy)-3-(trifluoromethyl)benzene, 98%, 5g

N1,N1'-(Ethane-1,2-diyl)bis(N1,N2,N2-trimethylethane-1,2-diamine), 97%, 5g

1-Hexadecyl-4-methylpyridinium Chloride>98.0%(T)5g

tert-Butyl 4-(S-methylsulfonimidoyl)piperidine-1-carboxylate, 95%, 100mg

4-(Trifluoromethyl)benzoic acid hydrazide, 95.0%, 100g

6-Bromopyridine-3-sulfonyl chloride, 95.0%, 5g

Dihydro-1-(3-iodophenyl)-2,4(1H,3H)-pyrimidinedione, 100mg

3-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]CYCLOBUTANONE, 95.0%, 10g

E-Plan phase EPLPH S40x/0.65 objective. Working distance 0.64 mm

1-Benzyl-3-methylpiperazine, 97.0%, 2g

2-(2-Dimethylamino-ethoxy)-ethylamine, 98.0%, 1g

Pyrazolo[1,5-a]pyridine-2-carbaldehyde, 95.0%, 500mg

Injection needles, 60 mm, 1.00 mm, 12 pieces